Evoke Pharma Outlines Progress on Clinical Program
February 2, 2015Evoke Pharma provides an update on its clinical program for EVK-001, its novel metoclopramide nasal spray for treating diabetic gastroparesis in women. Evoke is currently enrolling its Phase 3 multicenter clinical trial.
More »
aTyr Announces First FSHD Patient Study of Resolaris™ First Physiocrine-Based Therapeutic Administered to Patients
January 28, 2015aTyr Pharma announces the first patient in its Resolaris™ clinical trial. This is aTyr’s first Physiocrine-based clinical product candidate. It is being evaluated in patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic disease with
More »
Sebacia Announces Positive Results of Two Independent Clinical Studies in Acne
January 28, 2015Sebacia announces positive clinical results from its two European clinical trials evaluating its simple two-step, in-office gold microparticle acne treatment. The results showed significant reduction in acne and the treatment was well tolerated.
More »